Finance

Beta
Lists
ENTA:NASDAQ
Enanta Pharmaceuticals Inc
14,39 USD
+0,91%
(+0,13) 1D
8-июл., 10:24:56 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTA...
Open
14,06 USD
High
14,48 USD
Low
14,02 USD
Mkt. cap
415,82 млн
Avg. vol.
249,36 миң
Volume
6,76 миң
52-wk high
17,15 USD
52-wk low
6,44 USD
EPS
-2,59 USD
Beta
0,96
Shares outstanding
29,08 млн
No. of employees
120
Open
14,06 USD
High
14,48 USD
Low
14,02 USD
Mkt. cap
415,82 млн
Avg. vol.
249,36 миң
Volume
6,76 миң
52-wk high
17,15 USD
52-wk low
6,44 USD
EPS
-2,59 USD
Beta
0,96
Shares outstanding
29,08 млн
No. of employees
120
News stories
From sources across the web
About Enanta Pharmaceuticals Inc
CEO-
Employees120
Founded1995
HeadquartersУотертаун, Массачусетс, Америка Кошмо Штаттары
Sector-
Websiteenanta.com
Analyst ratings
Based on 1 analyst giving stock ratings to ENTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ENTA in the last 3 months
Highest
Current 14,39 USD
20,00 USD (+38,99%)
Average
20,00 USD (+38,99%)
Lowest
20,00 USD (+38,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
20,00 USD
+39%
06/23/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
20,00 USD
+39%
03/26/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
19,00 USD
+32%
03/03/2026
Last report
2026-ж., 11-май
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,45 USD / -0,57 USD
+20,82%beat
Revenue / Est. (USD)
17,16 млн / 16,58 млн
+3,51%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
18,31 млн
15,12 млн
18,62 млн
17,16 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
27,21 млн
23,81 млн
20,86 млн
19,44 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,00 млн
9,70 млн
9,01 млн
9,57 млн
Operating expense
37,21 млн
33,51 млн
29,87 млн
29,01 млн
Total operating expenses
37,21 млн
33,51 млн
29,87 млн
29,01 млн
Operating income
-18,89 млн
-18,39 млн
-11,25 млн
-11,85 млн
Other non operating income
-
39,00 миң
-
-
EBT including unusual items
-18,23 млн
-18,67 млн
-11,91 млн
-13,08 млн
EBT excluding unusual items
-18,23 млн
-19,63 млн
-11,89 млн
-13,08 млн
Income tax expense
29,00 миң
32,00 миң
24,00 миң
7,00 миң
Effective tax rate
-0,16%
-0,17%
-0,20%
-0,05%
Other operating expenses
-
-
-
-
Net income
-18,26 млн
-18,70 млн
-11,94 млн
-13,09 млн
Net profit margin
-99,68%
-123,64%
-64,13%
-76,29%
Earnings per share
-0,85
-0,87
-0,42
-0,45
Interest and investment income
2,28 млн
1,11 млн
2,44 млн
2,08 млн
Interest expense
-1,62 млн
-2,39 млн
-3,08 млн
-3,32 млн
Net interest expenses
667,00 миң
-1,28 млн
-641,00 миң
-1,23 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-17,68 млн
-17,10 млн
-10,02 млн
-10,64 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer